BIOMAT Database Logo BIOMAT Database Logo

Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. 2010

M J de Groot, and M Hoeksma, and N Blau, and D J Reijngoud, and F J van Spronsen
Beatrix Children's Hospital, University Medical Center Groningen, Groningen, The Netherlands.

In untreated phenylketonuria (PKU), deficiency of phenylalanine hydroxylase (PAH) results in elevated blood phenylalanine (Phe) concentrations and severe mental retardation. Current dietary treatment prevents mental retardation, but cognitive outcome remains suboptimal. The mechanisms by which elevated blood Phe concentrations disturb cerebral metabolism and cognitive function have not been fully elucidated. In this review, we discuss different hypotheses on the pathogenesis of PKU, focusing on the effects of disturbed large neutral amino acid (LNAA) transport from blood to brain on cerebral neurotransmitter and protein synthesis. Although the definitive roles of these processes in PKU pathogenesis are not fully understood yet, both substantially influence clinical outcome.

UI MeSH Term Description Entries
D010661 Phenylketonurias A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952). Biopterin Deficiency,Dihydropteridine Reductase Deficiency Disease,Hyperphenylalaninemia, Non-Phenylketonuric,Phenylalanine Hydroxylase Deficiency Disease,BH4 Deficiency,DHPR Deficiency,Deficiency Disease, Dihydropteridine Reductase,Deficiency Disease, Phenylalanine Hydroxylase,Deficiency Disease, Phenylalanine Hydroxylase, Severe,Dihydropteridine Reductase Deficiency,Folling Disease,Folling's Disease,HPABH4C,Hyperphenylalaninaemia,Hyperphenylalaninemia Caused by a Defect in Biopterin Metabolism,Hyperphenylalaninemia, BH4-Deficient, C,Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To DHPR Deficiency,Non-Phenylketonuric Hyperphenylalaninemia,Oligophrenia Phenylpyruvica,PAH Deficiency,PKU, Atypical,Phenylalanine Hydroxylase Deficiency,Phenylalanine Hydroxylase Deficiency Disease, Severe,Phenylketonuria,Phenylketonuria I,Phenylketonuria II,Phenylketonuria Type 2,Phenylketonuria, Atypical,Phenylketonuria, Classical,QDPR Deficiency,Quinoid Dihydropteridine Reductase Deficiency,Tetrahydrobiopterin Deficiency,Atypical PKU,Atypical Phenylketonuria,Biopterin Deficiencies,Classical Phenylketonuria,Deficiency, BH4,Deficiency, Biopterin,Deficiency, DHPR,Deficiency, Dihydropteridine Reductase,Deficiency, PAH,Deficiency, Phenylalanine Hydroxylase,Deficiency, QDPR,Deficiency, Tetrahydrobiopterin,Disease, Folling,Disease, Folling's,Hyperphenylalaninemia, Non Phenylketonuric,Non Phenylketonuric Hyperphenylalaninemia,Non-Phenylketonuric Hyperphenylalaninemias
D001812 Blood-Brain Barrier Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue. Brain-Blood Barrier,Hemato-Encephalic Barrier,Barrier, Blood-Brain,Barrier, Brain-Blood,Barrier, Hemato-Encephalic,Barriers, Blood-Brain,Barriers, Brain-Blood,Barriers, Hemato-Encephalic,Blood Brain Barrier,Blood-Brain Barriers,Brain Blood Barrier,Brain-Blood Barriers,Hemato Encephalic Barrier,Hemato-Encephalic Barriers
D003072 Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. Overinclusion,Disorder, Cognition,Disorders, Cognition
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D021542 Amino Acids, Neutral Amino acids with uncharged R groups or side chains. Neutral Amino Acids,Acids, Neutral Amino

Related Publications

M J de Groot, and M Hoeksma, and N Blau, and D J Reijngoud, and F J van Spronsen
[Pathogenesis of cerebral dysfunction in phenylketonuria].
January 1982, Revista espanola de fisiologia,
M J de Groot, and M Hoeksma, and N Blau, and D J Reijngoud, and F J van Spronsen
[Pathophysiology of post-operative cognitive dysfunction: current hypotheses].
January 2008, Journal de chirurgie,
M J de Groot, and M Hoeksma, and N Blau, and D J Reijngoud, and F J van Spronsen
Maternal phenylketonuria. Review with emphasis on pathogenesis.
January 1987, Enzyme,
M J de Groot, and M Hoeksma, and N Blau, and D J Reijngoud, and F J van Spronsen
Pathogenesis of irradiation-induced cognitive dysfunction.
January 1996, Acta oncologica (Stockholm, Sweden),
M J de Groot, and M Hoeksma, and N Blau, and D J Reijngoud, and F J van Spronsen
Pathogenesis of quinolone-induced arthropathy: a review of hypotheses.
January 2004, Polish journal of veterinary sciences,
M J de Groot, and M Hoeksma, and N Blau, and D J Reijngoud, and F J van Spronsen
The pathogenesis of phenylketonuria.
November 1965, GP,
M J de Groot, and M Hoeksma, and N Blau, and D J Reijngoud, and F J van Spronsen
Possible chemical initiators of cognitive dysfunction in phenylketonuria, Parkinson's disease and Alzheimer's disease.
October 2013, Medical hypotheses,
M J de Groot, and M Hoeksma, and N Blau, and D J Reijngoud, and F J van Spronsen
Pathogenesis and treatment of post-operative cognitive dysfunction.
February 2017, Electronic physician,
M J de Groot, and M Hoeksma, and N Blau, and D J Reijngoud, and F J van Spronsen
[Pathogenesis and diagnosis of phenylketonuria].
July 1968, Therapie der Gegenwart,
M J de Groot, and M Hoeksma, and N Blau, and D J Reijngoud, and F J van Spronsen
Birth weight and pathogenesis in phenylketonuria.
October 1990, The International journal of neuroscience,
Copied contents to your clipboard!